OPTI Medical Systems wins US FDA's EUA for OPTI SARS-CoV-2 RNA PCR Test Kit for detection of SARS-CoV-2.

Global Banking News-May 8, 2020-OPTI Medical Systems wins US FDA's EUA for OPTI SARS-CoV-2 RNA PCR Test Kit for detection of SARS-CoV-2

(C)2020 ENPublishing - http://www.enpublishing.co.uk

Diagnostics company OPTI Medical Systems Inc reported on Thursday the receipt of the US Food and Drug Administration's (FDA) Emergency Use Authorization (EUA) for the OPTI SARS-CoV-2 RT-PCR laboratory test kit for the detection of SARS-CoV-2 upon validation by the Institut Pasteur of France.

The company added that the OPTI SARS-CoV-2 RT-PCR test kit is based on real-time reverse transcription polymerase chain reaction (RT-PCR), which provides detection of the viral RNA in the sample. It is designed for the detection of SARS-CoV-2 RNA extracted from nasopharyngeal swabs, oropharyngeal swabs...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT